180 Life Sciences Corp.
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor ne…
Business Intelligence
Competitors · Subsidiaries · Locations · Network
This feature shows
the market relationships of 180 Life Sciences Corp.,
e.g. through tracking it's acquisitions, subsidiaries, offices,
fabrics and competitors around the globe.
Tip: If you see a dot, it's always worth scrolling up so that the map enlarges and points on top of each other (e.g. NYC vs. Fort Lee) can be differentiated.
U.S. · Business Intelligence
The U.S. map and table tracks offices, fabrics, competitors and subsidiaries located in the United States.
Worldwide · Business Intelligence
The worldwide map and table tracks NON-US offices, fabrics, competitors and subsidiaries.
Worldwide · Competitors Table
Sourced from FMP or manual.
| Competitor | Private? | Source | Accuracy | Country | City |
|---|---|---|---|---|---|
| Apexigen, Inc. | FMP | High | United States | San Carlos | |
| Phio Pharmaceuticals Corp. | FMP | High | United States | Marlborough | |
| Immix Biopharma, Inc. | FMP | High | United States | Los Angeles | |
| Sonnet BioTherapeutics Holdings, Inc. | FMP | High | United States | Princeton | |
| Cardio Diagnostics Holdings, Inc. | FMP | High | United States | Chicago | |
| Palisade Bio, Inc. | FMP | High | United States | Carlsbad | |
| Enveric Biosciences, Inc. | FMP | High | United States | Naples | |
| ZyVersa Therapeutics, Inc. | FMP | High | United States | Weston | |
| CNS Pharmaceuticals, Inc. | FMP | High | United States | Houston | |
| Zura Bio Limited | FMP | High | United States | San Diego | |
| eFFECTOR Therapeutics, Inc. | FMP | High | United States | Solana Beach |
Worldwide · Subsidiaries Table
Sourced from the SEC, through government awards and manual entries.
| Subsidiary | Private? | Country | City |
|---|---|---|---|
| - | - | - | - |